OncoSec Medical
San Diego
About OncoSec Medical
OncoSec Medical is an advanced-stage biomedical company that focuses on the development of novel therapeutic oncology products. The company's core technology is an untapped delivery system, that applies short electric impulses to a tumor, causing transient pores to open in the cellular membrane, allowing therapeutic agents to more readily enter cancer cells. This process is known as OMS electroporation. Using OMS electroporation in tandem with chemotherapeutic or biologic agents can selectively and effectively treat cancerous tumors and cells embedded among predominantly healthy tissue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $142.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2023)
- Ticker: nasdaq:ONCS
- Website: oncosec.com
- Phone: +1 858-662-6732
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/oncosec-medical-183941 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.